Abstract
In many types of human tumor cells and infectious agents, the demand for pyrimidine nitrogen bases increases during the development of the disease, thus increasing the role of the enzyme uridine phosphorylase in metabolic processes. The rational use of uridine phosphorylase and its ligands in pharmaceutical and biotechnology industries requires knowledge of the structural basis for the substrate specificity of the target enzyme. This paper summarizes the results of the systematic study of the three-dimensional structure of uridine phosphorylase from the pathogenic bacterium Vibrio cholerae in complexes with substrates of enzymatic reactions—uridine, phosphate anion, thymidine, uracil, and thymine. These data, supplemented with the results of molecular modeling, were used to consider in detail the structural basis for the substrate specificity of uridine phosphorylases. It was shown for the first time that the formation of a hydrogen-bond network between the 2′-hydroxy group of uridine and atoms of the active-site residues of uridine phosphorylase leads to conformational changes of the ribose moiety of uridine, resulting in an increase in the reactivity of uridine compared to thymidine. Since the binding of thymidine to residues of uridine phosphorylase causes a smaller local strain of the β-N1-glycosidic bond in this the substrate compared to the uridine molecule, the β-N1-glycosidic bond in thymidine is more stable and less reactive than that in uridine. It was shown for the first time that the phosphate anion, which is the second substrate bound at the active site, interacts simultaneously with the residues of the β5-strand and the β1-strand through hydrogen bonding, thus securing the gate loop in a conformation
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
A. Vita, A. Amici, T. Cacciamani, et al., Int. J. Biochem. 18 (5), 431 (1986).
J. C. Leer, K. Hammer-Jespersen, and M. Schwartz, Eur. J. Biochem. 75 (1), 217 (1977).
M. V. Dontsova, Y. A. Savochkina, A. G. Gabdoulkhakov, et al., Acta Crystallogr. D 60 (4), 709 (2004).
N. S. Brown and R. Bicknell, Biochem J. 334 (1), 1 (1998).
T. T. Caradoc-Davies, S. M. Cutfield, I. L. Lamont, et al., J. Mol. Biol. 337 (2), 337 (2004).
K. Katsumata, H. Tomioka, T. Sumi, et al., Cancer Chemother. Pharmacol. 51 (2), 155 (2003).
P. J. Finan, P. A. Koklitis, E. M. Chisholm, et al., Br. J. Cancer 50 (5), 711 (1984).
A. Leyva, I. Kraal, J. Lankelma, et al., Anticancer Res. 3 (4), 227 (1983).
A. Kanzaki, Y. Takebayashi, H. Bando, et al., Int. J. Cancer 97 (5), 631 (2002).
C. Luccioni, J. Beaumatin, V. Bardot, et al., Int. J. Cancer 58 (4), 517 (1994).
T. Ishikawa, M. Utoh, N. Sawada, et al., Biochem. Pharmacol. 55 (7), 1091 (1998).
B. Reigner, K. Blesch, and E. Weidekamm, Clin. Pharmacokinet. 40 (2), 85 (2001).
J. Schuller, J. Cassidy, E. Dumont, et al., Cancer. Chemother. Pharmacol. 45 (4), 291 (2000).
M. Venturini, Eur. J. Cancer 38 (Suppl. 2), 3 (2002).
E. Sivridis, Adv. Exp. Med. Biol. 476, 297 (2000).
T. P. Roosild, S. Castronovo, M. Fabbiani, et al., BMC Struct. Biol. 9, 14 (2009).
M. H. el Kouni, F. N. Naguib, J. G. Niedzwicki, et al., J. Biol. Chem. 263 (13), 6081 (1988).
B. M. Jimenez, P. Kranz, C. S. Lee, et al., Biochem. Pharmacol. 38 (21), 3785 (1989).
C. S. Lee, B. M. Jimenez, and W. J. O’Sullivan, Mol. Biochem. Parasitol. 30 (3), 271 (1988).
K. S. Alekseev, Candidate’s Dissertation in Chemistry (Engelhardt Institute of Molecular Biology, Moscow, 2012).
A. A. Lashkov, A. G. Gabdulkhakov, I. I. Prokofev, et al., Acta Crystallogr. F 68 (11), 1394 (2012).
I. I. Prokofev, A. A. Lashkov, A. G. Gabdulkhakov, et al., Acta Crystallogr. F 70, Part 1, 60 (2014).
M. Zolotukhina, I. Ovcharova, S. Eremina, et al., Res. Microbiol. 154 (7), 510 (2003).
W. Kabsch, Acta Crystallogr. D 66 (2), 133 (2010).
P. Evans, Acta Crystallogr. D 62, Part 1, 72 (2006).
A. Vagin and A. Teplyakov, J. Appl. Crystallogr. 30 (6), 1022 (1997).
A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, et al., J. Appl. Crystallogr. 40, Part 4, 658 (2007).
P. D. Adams, P. V. Afonine, G. Bunkoczi, et al., Acta Crystallogr. D 66, Part 2, 213 (2010).
G. N. Murshudov, A. A. Vagin, and E. J. Dodson, Acta Crystallogr. D 53 (3), 240 (1997).
P. Emsley and K. Cowtan, Acta Crystallogr. D 60 (12), 2126 (2004).
P. Emsley, B. Lohkamp, W. G. Scott, et al., Acta Crystallogr. D 66 (4), 486 (2010).
R. A. Laskowski, M. W. MacArthur, D. S. Moss, et al., J. Appl. Crystallogr. 26 (2), 283 (1993).
V. B. Chen, W. B. Headd. J. J. Arendall, et al., Acta Crystallogr. D 66 (1), 12 (2010).
W. L. Delano, The PyMOL Molecular Graphics System (2002). URL: http://www.pymol.orgciteulike-articleid: 2816763.
M. A. Larkin, G. Blackshields, N. P. Brown, et al., Bioinformatics 23 (21), 2947 (2007).
X. Robert and P. Gouet, Nucl. Acids Res. 42, 320 (2014).
A. C. Wallace, R. A. Laskowski, and J. M. Thornton, Protein Sci. 5 (6), 1001 (1996).
A. D. Bochevarov, E. Harder, T. F. Hughes, et al., Int. J. Quantum Chem. 113 (18), 2110 (2013).
C. R. Guimaraes and M. Cardozo, J. Chem. Inf. Model. 48 (5), 958 (2008).
J. L. Banks, H. S. Beard, Y. Cao, et al., J. Comput. Chem. 26 (16), 1752 (2005).
E. Polak and G. Ribiere, ESAIM: Mathematical Modelling and Numerical Analysis—Modélisation Mathématique et Analyse Numérique (1969), Vol. 3, p. 35.
X. Q. Xie and J. Z. Chen, J. Chem. Inf. Model. 48 (3), 465 (2008).
A. W. Schuttelkopf and D. M. Van Aalten, Acta Crystallogr. D 60 (8), 1355 (2004).
R. A. Friesner, J. L. Banks, R. B. Murphy, et al., J. Med. Chem. 47 (7), 1739 (2004).
S. Van der David, L. Erik, H. Berk, et al., J. Comput. Chem. 26 (16), 1701 (2005).
E. Krissinel and K. Henrick, J. Mol. Biol. 372 (3), 774 (2007).
A. A. Lashkov, S. E. Sotnichenko, I. I. Prokofiev, et al., Acta Crystallogr. D 68 (8), 968 (2012).
A. A. Lashkov, N. E. Zhukhlistova, A. H. Gabdoulkhakov, et al., Acta Crystallogr. D 66, Part 1, 51 (2010).
M. G. Rossmann and P. Argos, Annu. Rev. Biochem. 50, 497 (1981).
W. Bu, E. C. Settembre, M. H. Kouni, et al., Acta Crystallogr. D 61 (7), 863 (2005).
T. H. Tran, S. Christoffersen, P. W. Allan, et al., Biochemistry 50 (30), 6549 (2011).
T. Miyahara, H. Nakatsuji, and T. Wada, J. Phys. Chem. A 118 (16), 2931 (2014).
D. Cao, R. L. Russell, D. Zhang, et al., Cancer Res. 62 (8), 2313 (2002).
M. Iigo, K. Nishikata, and A. Hoshi, Jpn J. Cancer Res. 83 (4), 392 (1992).
C. J. Van Groeningen, G. J. Peters, and H. M. Pinedo, Semin. Oncol. 19 (2), 148 (1992).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.I. Prokofev, A.A. Lashkov, A.G. Gabdulkhakov, V.V. Balaev, T.A. Seregina, A.S. Mironov, C. Betzel, A.M. Mikhailov, 2016, published in Kristallografiya, 2016, Vol. 61, No. 6, pp. 919–939.
Rights and permissions
About this article
Cite this article
Prokofev, I.I., Lashkov, A.A., Gabdulkhakov, A.G. et al. X-ray structures of uridine phosphorylase from Vibrio cholerae in complexes with uridine, thymidine, uracil, thymine, and phosphate anion: Substrate specificity of bacterial uridine phosphorylases. Crystallogr. Rep. 61, 954–973 (2016). https://doi.org/10.1134/S1063774516060134
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1063774516060134